Anti-inflammatory and Antioxidant Effects of Captopril Compared to Methylprednisolone in l-Arginine-Induced Acute Pancreatitis
Acute pancreatitis (AP) is an inflammatory disease mediated by damage in acinar cells and pancreatic inflammation with infiltration of leukocytes. The pancreatic renin–angiotensin system may play an important role in the pathogenesis of AP.
The present study aimed to investigate the possible protective role of captopril (CAP), an angiotensin-converting enzyme inhibitor, in attenuating l-arginine-induced AP rat model and to elucidate the underlying molecular mechanisms.
Forty-eight adult male Wister rats were divided into four equal groups: control group (vehicle, orally for 10 days), AP group (3 g/kg l-arginine, single i.p.) on 10th day of the experiment, CAP group (50 mg/kg captopril, orally, once daily), and MP group (30 mg/kg methylprednisolone, orally, once daily). CAP and MP were administered for 10 days prior to l-arginine injection. Rats were sacrificed 24 h after arginine injection. Inflammatory biomarkers; tumor necrosis factor alpha (TNF-α) concentration, myeloperoxidase (MPO) activity, and inducible nitric oxide synthase (iNOS) gene expression were determined in pancreas. Oxidative stress biomarkers; pancreatic nitric oxide (NO) and reduced glutathione (GSH) concentrations were measured. Moreover, serum α-amylase and lipase activities were measured and histopathological studies of the pancreas were done.
CAP group showed a significant reduction in pancreatic TNF-α concentration, MPO activity, NO concentration, and downregulation of iNOS gene expression compared to AP group. CAP group also showed a significant increase in GSH concentration with amelioration of histological changes of AP as well as MP group.
Captopril treatment showed a protective and comparable effect with MP treatment in AP rat model.
KeywordsAcute pancreatitis Captopril iNOS Myeloperoxidase TNF-α
The authors gratefully acknowledge Dr. Mohammed Fawzy for his help in conducting and interpreting the histopathological investigations.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 12.Mikrut K, Kupsz J, Koźlik J, Krauss H, Pruszyńska-Oszmałek E, Gibas-Dorna M. Angiotensin-converting enzyme inhibitors reduce oxidative stress intensity in hyperglicemic conditions in rats independently from bradykinin receptor inhibitors. Croat Med J. 2016;57:371–380.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Hasan MI, Bakr AG, Shalkami A-GS. Modulation of l-arginine-induced acute pancreatitis by meloxicam and/or L-carnitine in rats. IJBCP. 2015;4:1247–1253.Google Scholar
- 30.Field A. Discovering statistics using SPSS. London: Sage Publications; 2009.Google Scholar
- 33.Biradar S. Naturally occurring active constituent can be one of the choice to treat acute pancreatitis. WJPPS. 2013;2:3878–3888.Google Scholar
- 40.Meng H, Liu Y, Li K, Li J. Comparison of the effects of methotrexate and methylprednisolone in spinal cord injury in rats. Drug Res. 2015;65:437–441.Google Scholar
- 41.Eid AH, Abdelkader NF, El-Raouf OMA, Fawzy HM, El-Denshary E-E-DS. Captopril and telmisartan ameliorate cisplatin-induced testicular damage in rats via anti-inflammatory and antioxidant pathways. IJSRP. 2016;6:408–420.Google Scholar
- 42.Moghadam Jafari A, Koohi MK, Ghazi-Khansari M, Pasalar P. Protective effects of captopril against aflatoxin b1-induced hepatotoxicity in isolated perfused rat liver. Zahedan J Res Med Sci. 2014;16:29–32.Google Scholar